Published on Jul 2, 2020
OneProjects is combining imaging and data analytics for the treatment of atrial fibrillation
The privately held company, which originated from Bioinnovate Ireland and Trinity College Dublin, raised $12.3M in a June 2020 Series A round. OneProjects touts its VERAFEYE imaging technology as a connected platform for the treatment of atrial fibrillation and cardiac arrhythmia. Strategic competitors in this space include Medtronic, Philips, and Johnson & Johnson.
Synthetic valve developer Foldax raises $20M in Series D round
The company is developing non-thrombogenic aortic and mitral valves. To-date the company has raised $33.9M. The heart valves market has become increasingly more competitive with the adoption of transcather valve repair and replacement techniques. Major competitors in this market include Boston Scientific, Edwards Lifesciences, and Medtronic.
Rapid, cost-effective, radiation-free image-guided surgery from 7D Surgical
The 7D surgical system uses patented machine-vision image guided surgery (MvIGS) to provide surgeons with a radiation-free navigation system for cranial and spinal surgery. Stryker, Brainlab, and Medtronic are some of the key strategics that offer image-guided surgery systems for spine/cranial surgery.
Aether Biomedical’s Zeus is a multi-action bionic limb for upper limb amputees
The company raised an undisclosed amount during a recent Seed round led by Chiratae Ventures. Aether Biomedical claims that their bionic limb offers one of the highest grip forces as compared to other bionic limbs, at an affordable rate. Other competitors in the bionic limb replacement market include Open Bionics, Mobius Bionics, and Ekso Bionics.
Candesant Biomedical is treating hyperhidrosis with a unique wearable
Combining akali metals with a wearable, bi-layer patch, Candesant is leveraging its technology to treat excessive sweating in the underarms, hands, and face. To-date the company has raised $9.1M. Sientra, DermaDry, and Hidrex currently develop and commercialize solutions for hyperhidrosis.
A fully implantable continuous dialysis device is in preclinical development at Nephrodite
Holly is a patent protected implantable dialysis device. The company is currently seeking investment partners. Several university-affiliated teams are currently developing and testing implantable dialysis machines in the hopes of developing an alternative to dialysis clinics.
Aksense is developing a rapid, point-of-care diagnostic for the diagnosis of bacterial infections
The blood analysis biosensor turns a smartphone into a rapid POC capable of detecting bacterial infections in under 5 minutes. Abbott, BD, and Roche are some of the key strategics in the point-of-care market today.
Learn more about these innovative start-ups and track other companies driving innovation in medtech by starting a trial to LSI's Medtech Start-Up Tracker.
LSI's global events attract top innovators, active investors, and deal-making strategics.GET INFO